BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 28480609)

  • 1. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
    Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
    J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
    Canellas R; Burk KS; Parakh A; Sahani DV
    AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors.
    Paiella S; Impellizzeri H; Zanolin E; Marchegiani G; Miotto M; Malpaga A; De Robertis R; D'Onofrio M; Rusev B; Capelli P; Cingarlini S; Butturini G; Davì MV; Amodio A; Bassi C; Scarpa A; Salvia R; Landoni L
    World J Gastroenterol; 2017 May; 23(17):3092-3098. PubMed ID: 28533666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic neuroendocrine tumors: MR imaging features preoperatively predict lymph node metastasis.
    Sun H; Zhou J; Liu K; Shen T; Wang X; Wang X
    Abdom Radiol (NY); 2019 Mar; 44(3):1000-1009. PubMed ID: 30539251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection.
    Sun HT; Zhang SL; Liu K; Zhou JJ; Wang XX; Shen TT; Song XH; Guo YL; Wang XL
    J Magn Reson Imaging; 2019 Aug; 50(2):397-409. PubMed ID: 30589158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
    Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
    Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma.
    Arabadzhieva E; Yonkov A; Bonev S; Bulanov D; Taneva I; Vlahova A; Dikov T; Dimitrova V
    World J Surg Oncol; 2016 Nov; 14(1):287. PubMed ID: 27846844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
    Li JK; Wang M; Yuan J; Song ZG
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroenteropancreatic neuroendocrine tumors: impact of consistent contrast agent selection on radiologists' confidence in hepatic lesion assessment on restaging MRIs.
    Balthazar P; Shinagare AB; Tirumani SH; Jagannathan JP; Ramaiya NH; Khorasani R
    Abdom Radiol (NY); 2018 Jun; 43(6):1386-1392. PubMed ID: 28840281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature.
    Mortaji P; Morris KT; Samedi V; Eberhardt S; Ryan S
    Fam Cancer; 2018 Apr; 17(2):275-280. PubMed ID: 28887784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.
    Sadowski SM; Millo C; Neychev V; Aufforth R; Keutgen X; Glanville J; Alimchandani M; Nilubol N; Herscovitch P; Quezado M; Kebebew E
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S676-82. PubMed ID: 26350374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of recurrence after surgery based on preoperative MRI features in patients with pancreatic neuroendocrine tumors.
    Han S; Kim JH; Yoo J; Jang S
    Eur Radiol; 2022 Apr; 32(4):2506-2517. PubMed ID: 34647178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.
    Jin F; Wang K; Qin TT; Li X; Guo F; Ma GN; Hu XH; Han P
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):587-595. PubMed ID: 28786064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Tumor Prognosis of Pancreatic Neuroendocrine Tumors Using Image, Surgical and Pathologic Findings.
    Chen F; Huang Y; Chen C; Zhang Y; Zhang Y; Wan R; Xu M
    Neuro Endocrinol Lett; 2023 Oct; 44(7):453-464. PubMed ID: 37874552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
    Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
    Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse Bone Metastases in Pancreatic Neuroendocrine Tumor Shown on Octreoscan.
    Adkins J; Lu Y
    Clin Nucl Med; 2019 Mar; 44(3):257-258. PubMed ID: 30624276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.